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Prompt and accurate diagnosis of malaria is part of an effective disease management 
(1)
, 
because if not treated malaria can quickly become life-threatening, whereas false 
positives increase treatment costs and drug-induced resistance, giving a wrong idea of 
therapeutic efficacy. Since the symptoms of malaria are nonspecific, the observation of 
clinical features alone might not be enough and should be confirmed with a 
parasitological analysis. Microscopic examination of Giemsa-stained thin and/or thick 
blood smears remains the conventional approach for diagnosis 
(2)
. The sensitivity of this 
relatively inexpensive method is excellent, allowing the detection of as few as 5 
parasites per µL of blood, and permitting also the determination of the infecting species 
and of the developmental stage of circulating parasites. In addition, smears provide a 
permanent record for quality assessment of the diagnosis. However, microscopy 
requires considerable expertise learned through extended training, the procedure is 
labor-intensive and time-consuming, and the variability in stains and in techniques used 
to collect and process blood affects slide interpretation 
(3)
. Finally, routine clinical 
microscopy cannot reliably detect very low parasitemias (<5 parasites/µL) or 
sequestered parasites, and mixed infections are often missed, especially when 
Plasmodium malariae and Plasmodium ovale are present, as their densities are often 
low relative to Plasmodium falciparum 
(4)
. 
Alternative methods to microscopy include immunochromatographic analyses 
based on the detection of some antigens either specific to a Plasmodium species like P. 
falciparum histidine-rich protein 2 (HRP2), or conserved across all human malarias 
such as Plasmodium lactate dehydrogenase and aldolase. Most of these approaches have 
led to commercially available rapid diagnostic tests (RDTs) 
(5)
, which have the 
advantages of being fast and simple without requiring extensive training or equipment. 
The results of the test should be rapidly available while the physician is actively 
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managing patients, typically in less than one hour 
(6)
, and the stability of RDT 
components should be such that refrigeration and a cold chain are not needed, whereas 
storage shelf life should be of sufficient long duration to minimize the logistical burden 
of resupply. A RDT strip chip has been designed for diagnosis of malaria infection 
(7)
, 
where different lines clearly visible to the naked eye indicate the presence of specific 
antigens in blood. Developments in nanoparticle-based immunochromatographic RDTs 
reached modest sensitivities of ≤500 P. falciparum/µL (8), although a test has been 
successfully evaluated for field use 
(9)
. Most current RDTs, though, involve some 
important limitations 
(10)
, such as the inability to simultaneously detect multiple strains 
and a too high detection threshold when considering the low level of parasitemia for 
immune populations, as well as for patients treated with antimalarial chemoprophylaxis. 
These gaps point out the need to develop new simple and rapid diagnostic tools showing 
higher sensitivity, selectivity and accuracy. Such a new generation of diagnostic devices 
should enable prediction of the therapeutic response at the beginning of a treatment, 
avoid the problems related to false positives and negatives, and be also capable of 
characterizing the precise infective Plasmodium species and strain through multiplexed 
measurements for the identification of parasite-specific antigens or enzymes. 
Malaria parasites inside Plasmodium-infected red blood cells (pRBCs) grow 
hemozoin crystals which under an external magnetic field induce concentration-
dependent optical dichroism. These magneto-optic properties have been harnessed for 
parasite detection in blood and tissues with low interference of other biological 
compounds 
(11)
. More recently, PCR-based point-of-care tests have been adapted for the 
detection of low levels of strain-specific parasites 
(12)
, even with saliva and urine as 
alternative DNA sources 
(13)
, although their use is very limited in resource-poor settings. 
The application of lab-on-a-chip (LOC) technology 
(14)
 could introduce a significant 
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improvement in rapid malaria diagnosis, parasitemia quantification, and monitoring of 
the evolution of the disease and of the effect of drugs. This technology is based on 
devices of small dimensions incorporating micro- and nanotechnologies able to perform 
several analytical laboratory operations. LOCs exploit microfluidic effects to allow an 
expansion of the analyte detection range, increased sensitivity, and reduction of the 
required sample and reagent amounts. In addition to performing most of the analytical 
operations in a safe and contamination-free environment, LOC devices can be made 
with cheap polymeric materials adequate for low cost and disposable tests. Efficacious 
portable on-the-field diagnostic tools can be assembled combining LOC cartridges, 
where the blood sample would be introduced, with simple electronics to actuate them 
and read out the test results.  
Microfluidics-based technology has potential for the design of point-of-care 
malaria diagnosis 
(15)
. It has been suggested that in some cases the capillary blockage 
induced by pRBCs in severe malaria is due to loss of cell deformability 
(16)
, likely 
triggered by an alteration in surface charge and plasticity of infected cells, a 
phenomenon which allows separating non-parasitized RBCs from pRBCs using 
dielectrophoretic forces 
(17)
. Free flow electrophoresis is a continuous separation and 
preparative technique where an electric field is applied perpendicular to a sample stream 
that is continuously pumped into a separation cavity, which has been shown to be useful 
in a number of applications including cell sorting. The separation of pRBCs from RBCs 
is possible due to the alteration of the electrical conductivity of erythrocyte membranes, 
which significantly increases when RBCs become host to malaria parasites 
(18)
. Free 
flow electrophoresis using a microfluidic system could provide an ideal platform for the 
development of a pRBC sorter by exploiting the advantages of low sample amounts and 
fast analysis times. Many groups are focusing their research on this type of devices, but 
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progress is still needed to reduce costs; one example is the European Commission (EC)-
funded NanoMal project 
(19)
, which is developing a simple, rapid and affordable point-
of-care handheld system for malaria diagnosis and detection of drug resistant parasites 
within minutes. Another EC-funded project is DiscoGnosis 
(20)
, where a disc-shaped 
plastic disposable chip handles a blood sample which is distributed among integrated 
chambers using centrifugal forces and microfluidic unit operations; all necessary 
(bio)chemicals are pre-stored in the disc, together with micro/nanocomponents, for fully 
automated analysis. 
An interesting alternative approach is based on the isothermal conversion of 
single DNA cleavage-ligation events, catalyzed specifically by the Plasmodium enzyme 
topoisomerase I, to products detected at the individual molecule level 
(21)
. This strategy 
allowed, combined with a droplet microfluidics LOC platform, for sensitive, specific, 
and quantitative detection of less than one parasite/µL of all human malaria-causing 
Plasmodium species in single drops of unprocessed blood. The setup also allowed for 
detection of parasites in noninvasive saliva samples from infected patients. In terms of 
detection limit this assay outcompetes state-of-the-art light microscopy (5 parasites/µL) 
and RDTs (≥200 parasites/µL), whereas in comparison to PCR, which is the only 
method with comparable sensitivity, the LOC system described is directly quantitative 
and requires no sample preparation. However, LOC-based devices require unambiguous 
and automated read-out formats and a simplified, pumpless syringe-based inlet system 
not available yet. Nevertheless, even in the current proof-of-concept setup, time-to-
readout (ca. 2.5 h) and price (ca. 2 USD/sample) suggest that such prototypes might be 
acceptable for routine use 
(21)
. Last but not least, since topoisomerase I is an essential 
enzyme conserved across all Plasmodium species, the above described LOC platform 
might be developed into a highly sensitive and specific pan-malaria test, in contrast to 
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many of the common commercially available RDTs specific for biomarkers such as 
HRP2, which detect P. falciparum only and are further hampered in regions where hrp2 
genes are not expressed in a significant proportion of parasites 
(22)
. On the other hand, 
such universal detection of Plasmodium goes against the need of diagnosis systems 
capable of rapidly discriminating different species and strains. 
A low-cost microfluidic LOC for rapid genotyping of malaria-transmitting 
mosquitoes has also been recently described 
(23)
. Several dozen Anopheles species are 
vectors of Plasmodium, some of which are difficult to distinguish morphologically, 
although this is fundamental to the development of control strategies and 
epidemiological studies of disease transmission. The inexpensive (<2 USD/test), 
disposable, field-deployable, and sample-to-answer microfluidic chip was developed for 
rapid molecular identification of Anopheles gambiae and Anopheles arabiensis using 
three isothermal DNA amplification reactors where crushed mosquito tissue was fed. 
The specific amplification products were labeled with an intercalating fluorescent dye 
whose emitted light was observed by eye and could be recorded with a cell-phone 
camera, which can be used for record keeping, transfer of data to a central processing 
facility, and for the provision of space and time stamps. 
Because the sulfated polysaccharide heparin and other glycosaminoglycans 
(GAGs) have been demonstrated to bind pRBCs with high specificity and affinity in 
comparison to RBCs 
(24,25,26)
, this property can potentially be harnessed for the design of 
novel RDTs based on GAG-pRBC recognition. In a preliminary assay, heparin was 
micropatterned onto perfluoropolyether-based polymers via photobiotin activation 
(27)
, 
although these arrays did not provide sufficiently specific pRBC recognition. The main 
identified risks were: (i) developing an adequate immobilizing strategy of GAGs on 
solid substrates, which will likely involve the use of linkers and an important chemistry 
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work; (ii) designing a method for sample treatment in order to expose to GAG-coated 
areas in the chip whole pRBCs or pRBC membranes, with the capability of washing 
away unbound components; and (iii) establishing a simple protocol for increasing 
sample signal with the objective of improving the sensitivity for the detection of low 
parasitemias. 
If these pitfalls can be successfully dealt with, GAG-based RDTs would have 
several advantages relative to current antibody-based RDTs: (i) GAGs are more sturdy 
than proteins (antibodies) in front of the harsh environmental conditions found in 
malaria endemic regions; foreseeingly, a GAG-based RDT will not require cold storage 
and can last for months at temperatures close to 40 °C if adequately stored dry and in 
the dark. (ii) GAG production is more economically affordable than that of antibodies. 
(iii) Given the absence of known resistances of Plasmodium to heparin, it can be 
speculated that the antimalarial mechanism of sulfated polysaccharides has some 
component based on complex interactions with the pRBC membrane; if so, a GAG-
based RDT might be used for pan-malaria diagnosis and would not be so susceptible to 
the elevated clonal variability of the parasite as antibody-based devices based on the 
recognition of small antigenic determinants. 
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